Could Allelic Discrimination in ETS2 Predispose Individuals to Breast Cancer?
The Open Breast Cancer Journal · 2010
DOI: 10.2174/1876817201002010001 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Open Breast Cancer Journal, 2010. Verfasst von Arpita Chatterjee und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
The V-ets erythroblastosis virus E26 oncogene homolog2 (ETS2) is known to have a stimulatory role in breast cancer progression.To find out its participation in the development of breast cancer, we have investigated a functional polymorphism in ETS2, rs461155, in a group of breast cancer patients.Allelic and genotypic frequencies obtained were compared with that obtained for ethnically matched healthy control individuals and data reported for four other ethnic groups in the HapMap project.Significant differences in genotypic frequencies were obtained between breast cancer patients and control individuals (p
Zitieren
APA
Chatterjee, A., Mukherjee, N., Panda, C. K., & Mukhopadhyay, K. (2010). Could Allelic Discrimination in ETS2 Predispose Individuals to Breast Cancer?. The Open Breast Cancer Journal. https://doi.org/10.2174/1876817201002010001
Vancouver
Chatterjee A, Mukherjee N, Panda CK, Mukhopadhyay K. Could Allelic Discrimination in ETS2 Predispose Individuals to Breast Cancer?. The Open Breast Cancer Journal. 2010. doi:10.2174/1876817201002010001
BibTeX
@article{Chatterjee2010,
author = {Chatterjee, Arpita and Mukherjee, Nupur and Panda, Chinmay Kumar and Mukhopadhyay, Kanchan},
title = {Could Allelic Discrimination in ETS2 Predispose Individuals to Breast Cancer?},
journal = {The Open Breast Cancer Journal},
year = {2010},
doi = {10.2174/1876817201002010001}
}
EUVIMED